News

Collaboration will be powered by tech company’s AI services

Acquisition helps grow its CDMO capabilities

In effort to assist pharma supply chain, company’s end goal is net-zero emissions by 2040

“Amplified iteration” advances the company’s ‘select, connect, discover’ insights management solution launched last year

Financial commitment expected to benefit capabilities of single-use assemblies

Allows CDMO’s regulatory, consulting services to further expand into the pharma market

Law firm to feature life sciences practice in New Jersey and Philadelphia

Among goals, product aims to mitigate supply chain risk for pharma and biotech industries

Varcode’s variable barcode records temperature and time out-of-compliance for pharma and perishables

Allows CDMO to enhance its therapeutic and vaccine offerings

Advanco provides software solution architecture and configuration while Vantage delivers design, implementation, and validation services

The Advanced Pharmaceutical Manufacturing (APM) Cluster, led by the Virginia Biotechnology Research Partnership Authority (Activation Capital), secures almost $53 million from the EDA’s Build Back Better Regional Challenge to boost Virginia’s pharmaceutical industry

Location expands company’s pharmacovigilance, regulatory affairs services

Shots target Omicron's BA.4 and BA.5 subvariants

Will feature additional cell and gene therapy capacity

Collaboration expected to accelerate the bionnovative drug R&D process

The latest people news happenings over the past month

Massachusetts facility will support biologics developers in the New England area

Illinois branch makes it the company's sixth new location in 2022

Massachusetts facility will be dedicated to offering viral vector production services

Company’s Conroe location will serve as HQ

If authorized by FDA, will arrive in time for possible fall and winter surges

CDMO’s 76,000 square-foot manufacturing center will be commercial ready

Track-and-trace provider will be incorporating fingerprinting tech into its line

CDMO filling capacity now exceeds 50 million units yearly

Company’s 344,000 square-foot facility revolves around pharma and medical items

Partnership adds technological offerings to PharmaLex’s repertoire

Site expected to boost the CDMO’s global drug production capabilities

The shot targets the original variant, along with Omicron

Agreement is centered around expanding medication access to patients